Skip to content

The effect of vascular stromal cells and platelet-rich plasma in the treatment of osteochondral lesions of the talus

Therapeutic impact of Adipose-derived Stromal Vascular Fraction And Platelet-rich plasma on non-operative treatment of osteochondral lesions of the talus: A Randomized Controlled Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231212060345N1
Enrollment
40
Registered
2024-02-04
Start date
2024-01-05
Completion date
Unknown
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

talus osteochondral lesions- talus osteochondritis dissecans. Osteochondritis dissecans of ankle and joints of foot

Interventions

Intervention 1: Intervention group: intra-articular injection of vascular stromal cells taken from fat, necessary equipment, svf extraction kit-syringe, SVF preparation: about 100 mL of adipose tissue

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: The symptoms have been continuous for at least 3 months and have not responded to conservative treatment age 18-70 years Patients with grade I, II Bernadet and Harry classification lesions CT SCAN and MRI confirm the diagnosis and no other pathology is involved The patient has the ability to understand the explanations and registers her verbal and written wishes in the informed consent form

Exclusion criteria

Exclusion criteria: presence of inflammatory arthritis such as rheumatoid arthritis, other systemic diseases such as diabetes and systemic inflammatory diseases; Systemic infection History of cardiovascular disease such as previous stroke or heart failure or coagulation problem such as disturbed PT, PTT, INR Any surgery or intra-articular injection Drug users or alcoholics Pregnancy or breastfeeding Severe weight loss in such a way that liposuction is not possible. Abdominal hernia The presence of loose bodies, osteoarthritic changes, impingement spurs, or other pathology

Design outcomes

Primary

MeasureTime frame
Diameter of Lesion. Timepoint: before entering the study - six months later. Method of measurement: CT scan.

Secondary

MeasureTime frame
Function of ankle. Timepoint: before entering the study - one month later - three months later - six months later. Method of measurement: American Orthopedic Foot and Ankle Society questionnaire.;Pain. Timepoint: before entering the study - one month later - three months later - six months later. Method of measurement: visual analog scale.;Osteoarthritis changes. Timepoint: before entering the study - one month later - three months later - six months later. Method of measurement: Ankle osteoarthritis scale questionnaire.;Lesion grade. Timepoint: before entering the study - six months later. Method of measurement: CT scan - Berndet and harty classification.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSina Hajiaghajani

Shahid Beheshti University of Medical Sciences

sinaaghajani1379@gmail.com+98 21 2610 6712

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026